iScience (Jul 2024)

Prospective cohort studies underscore the association of abnormal glycemic measures with all-cause and cause-specific mortalities

  • Juzhong Ke,
  • Xiaonan Ruan,
  • Wenbin Liu,
  • Xiaolin Liu,
  • Kang Wu,
  • Hua Qiu,
  • Xiaonan Wang,
  • Yibo Ding,
  • Xiaojie Tan,
  • Zhitao Li,
  • Guangwen Cao

Journal volume & issue
Vol. 27, no. 7
p. 110233

Abstract

Read online

Summary: The role of fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), and triglyceride-glucose index (TyG index) in predicting all-cause and cause-specific mortalities remains elusive. This study included 384,420 adults from the Shanghai cohort and the UK Biobank (UKB) cohort. After multivariable adjustment in the Cox models, FPG ≥7.0 mmol/L or HbA1c ≥ 6.5% increased the risk of all-cause mortality, FPG ≥5.6 mmol/L or HbA1c ≥ 6.5% increased CVD-related mortality, and higher or lower TyG index increased all-cause and CVD-related mortalities in the Shanghai cohort; FPG ≥5.6 mmol/L, HbA1c ≥ 5.7%, TyG index <8.31 or ≥9.08 increased the risks of all-cause, CVD-related, and cancer-related mortalities in the UKB cohort. FPG or HbA1c increased the discrimination of the conventional risk model in predicting all-cause and CVD-related mortalities in both cohorts. Thus, increased levels of FPG and HbA1c and U-shaped TyG index increase the risks of all-cause especially CVD-related mortalities.

Keywords